We close out Season 2 with a conversion with Helena Yin Koeppl of Bayer. Like many of our guests over the first two seasons, Helena has held analytics leadership roles at some of the world’s most recognized consumer and healthcare brands. Helena now oversees building the strategic vision as well as the analytics portfolio and roadmap for a brand-new function in Bayer’s Pharmaceutical division. She has designed a growing organization that enables advanced analytics, artificial intelligence, and machine learning to drive business outcomes across therapeutic areas and markets at Bayer.